4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000919574-17-008354
Director bought 45,200 shares at an average $1.20 ($54,190)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-22 | Purchase : show line 1 in the form | +5,200 | $1.21 | $6,273 | 16,010,000 | D |
| 2017-11-22 | Purchase : show line 2 in the form | +0 | 16,010,000 | I | ||
| 2017-11-22 | Purchase : show line 3 in the form | +0 | 16,010,000 | I | ||
| 2017-11-22 | Purchase : show line 4 in the form | +30,000 | $1.20 | $35,937 | 16,040,000 | D |
| 2017-11-22 | Purchase : show line 5 in the form | +0 | 16,040,000 | I | ||
| 2017-11-22 | Purchase : show line 6 in the form | +0 | 16,040,000 | I | ||
| 2017-11-24 | Purchase : show line 7 in the form | +5,000 | $1.20 | $5,990 | 16,045,000 | D |
| 2017-11-24 | Purchase : show line 8 in the form | +0 | 16,045,000 | I | ||
| Open-market purchases · 45,200 sh · avg $1.20 · $54,190 | ||||||
Loading xslF345X03/p7745463.xml…